Remember to assess the ‘whole’ patient: a further immune‐related adverse event of programmed cell death 1 checkpoint inhibition
Author:
- 18 December 2019
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (2) , 276-277
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A reviewSeminars in Cancer Biology, 2020
- Acquired generalized lipodystrophy under immune checkpoint inhibitionBritish Journal of Dermatology, 2019
- Dermatologic Reactions to Immune Checkpoint InhibitorsAmerican Journal of Clinical Dermatology, 2017
- Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their managementCancer Treatment Reviews, 2017
- Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohortJournal of the American Academy of Dermatology, 2016